WallStSmart

CareCloud, Inc. (CCLD)vsHealthEquity Inc (HQY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HealthEquity Inc generates 977% more annual revenue ($1.34B vs $124.14M). HQY leads profitability with a 17.2% profit margin vs 7.9%. CCLD appears more attractively valued with a PEG of 0.31. HQY earns a higher WallStSmart Score of 66/100 (B-).

CCLD

Strong Buy

66

out of 100

Grade: B-

Growth: 6.0Profit: 6.0Value: 8.7Quality: 6.5
Piotroski: 3/9Altman Z: 2.20

HQY

Strong Buy

66

out of 100

Grade: B-

Growth: 8.0Profit: 7.5Value: 6.7Quality: 7.8
Piotroski: 7/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CCLDUndervalued (+58.0%)

Margin of Safety

+58.0%

Fair Value

$5.33

Current Price

$2.35

$2.98 discount

UndervaluedFair: $5.33Overvalued
HQYUndervalued (+49.2%)

Margin of Safety

+49.2%

Fair Value

$151.32

Current Price

$88.67

$62.65 discount

UndervaluedFair: $151.32Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCLD4 strengths · Avg: 9.5/10
PEG RatioValuation
0.3110/10

Growing faster than its price suggests

EPS GrowthGrowth
5739.0%10/10

Earnings expanding 5739.0% YoY

Debt/EquityHealth
0.1010/10

Conservative balance sheet, low leverage

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

HQY2 strengths · Avg: 8.0/10
Operating MarginProfitability
29.3%8/10

Strong operational efficiency at 29.3%

EPS GrowthGrowth
34.4%8/10

Earnings expanding 34.4% YoY

Areas to Watch

CCLD4 concerns · Avg: 3.0/10
Market CapQuality
$99.86M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
7.9%3/10

7.9% margin — thin

Operating MarginProfitability
3.4%3/10

Operating margin of 3.4%

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

HQY1 concerns · Avg: 4.0/10
P/E RatioValuation
33.1x4/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : CCLD

The strongest argument for CCLD centers on PEG Ratio, EPS Growth, Debt/Equity. Revenue growth of 13.2% demonstrates continued momentum. PEG of 0.31 suggests the stock is reasonably priced for its growth.

Bull Case : HQY

The strongest argument for HQY centers on Operating Margin, EPS Growth. Profitability is solid with margins at 17.2% and operating margin at 29.3%. PEG of 1.27 suggests the stock is reasonably priced for its growth.

Bear Case : CCLD

The primary concerns for CCLD are Market Cap, Profit Margin, Operating Margin.

Bear Case : HQY

The primary concerns for HQY are P/E Ratio.

Key Dynamics to Monitor

CCLD profiles as a value stock while HQY is a mature play — different risk/reward profiles.

CCLD carries more volatility with a beta of 1.60 — expect wider price swings.

CCLD is growing revenue faster at 13.2% — sustainability is the question.

HQY generates stronger free cash flow (97M), providing more financial flexibility.

Bottom Line

CCLD scores higher overall (66/100 vs 66/100) and 13.2% revenue growth. HQY offers better value entry with a 49.2% margin of safety. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CareCloud, Inc.

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. The company is headquartered in Somerset, New Jersey.

Visit Website →

HealthEquity Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

HealthEquity, Inc. provides technology-enabled service platforms to consumers and employers in the United States. The company is headquartered in Draper, Utah.

Want to dig deeper into these stocks?